OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors
Edward M. Wolin, Amandine Manon, Christophe Chassaing, et al.
Journal of Gastrointestinal Cancer (2016) Vol. 47, Iss. 4, pp. 366-374
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

A Comprehensive Map of FDA-Approved Pharmaceutical Products
Hao Zhong, Ging Chan, Hu Y, et al.
Pharmaceutics (2018) Vol. 10, Iss. 4, pp. 263-263
Open Access | Times Cited: 252

Challenges and Opportunities in the Delivery of Cancer Therapeutics: Update on Recent Progress
Mathilde Lorscheider, Alice Gaudin, Jessica Nakhlé, et al.
Therapeutic Delivery (2020) Vol. 12, Iss. 1, pp. 55-76
Closed Access | Times Cited: 82

Self-Assembling Peptides: From Design to Biomedical Applications
Sara La Manna, Concetta Di Natale, Valentina Onesto, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12662-12662
Open Access | Times Cited: 73

Sustained Release Systems for Delivery of Therapeutic Peptide/Protein
Tianqi Nie, Wei Wang, Xiaohu Liu, et al.
Biomacromolecules (2021) Vol. 22, Iss. 6, pp. 2299-2324
Closed Access | Times Cited: 43

Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects
J. Richard
Therapeutic Delivery (2017) Vol. 8, Iss. 8, pp. 663-684
Closed Access | Times Cited: 56

Cyclic peptides: a powerful instrument for advancing biomedical nanotechnologies and drug development
Paul Cristian Martian, Mihaela Tertiş, Denisa Leonte, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 252, pp. 116488-116488
Open Access | Times Cited: 6

Just how prevalent are peptide therapeutic products? A critical review
Yajie Zhang, Hairui Zhang, Debadyuti Ghosh, et al.
International Journal of Pharmaceutics (2020) Vol. 587, pp. 119491-119491
Open Access | Times Cited: 38

Structural Characterization of PEGylated Hexaphenylalanine Nanostructures Exhibiting Green Photoluminescence Emission
Carlo Diaferia, Teresa Sibillano, Davide Altamura, et al.
Chemistry - A European Journal (2017) Vol. 23, Iss. 56, pp. 14039-14048
Closed Access | Times Cited: 37

The industrial design, translation, and development strategies for long-acting peptide delivery
Bin Yang, Ana Gomes dos Santos, Sanyogitta Puri, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 10, pp. 1233-1245
Closed Access | Times Cited: 14

Identification of Key Genes as Potential Drug Targets for Gastric Cancer
Md. Tofazzal Hossain, Md. Selim Reza, Yin Peng, et al.
Tsinghua Science & Technology (2023) Vol. 28, Iss. 4, pp. 649-664
Open Access | Times Cited: 6

Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in Japan
Akira Shimatsu, Akinobu Nakamura, Yutaka Takahashi, et al.
Endocrine Journal (2021) Vol. 68, Iss. 7, pp. 791-805
Open Access | Times Cited: 11

A phase II trial of lanreotide for the prevention of postoperative pancreatic fistula
Venu G. Pillarisetty, Arezou Abbasi, James O. Park, et al.
HPB (2022) Vol. 24, Iss. 11, pp. 2029-2034
Open Access | Times Cited: 6

The Chemical Methods of Disulfide Bond Formation and Their Applications to Drug Conjugates
Rongjun He, Jia Pan, John P. Mayer, et al.
Current Organic Chemistry (2019) Vol. 23, Iss. 25, pp. 2802-2821
Closed Access | Times Cited: 5

Selective internal radiation therapy: an effective treatment for hormonal syndromes in pancreatic neuroendocrine tumors
Leyre Zubiri, José Ignacio Bilbao, Javier Rodríguez, et al.
Hepatic Oncology (2018) Vol. 5, Iss. 2
Open Access | Times Cited: 3

On-resin synthesis of Lanreotide epimers and studies of their structure-activity relationships
Arnab Chowdhury, Nitesh Mani Tripathi, Rohit Jadav, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 8, pp. 2766-2772
Closed Access

β-Cyclodextrin Derivatives Bind Aromatic Side Chains of the Cyclic Peptide Lanreotide
Negar Jafari, Justin T. Douglas, Sarah A. Neuenswander, et al.
Journal of Pharmaceutical Sciences (2024)
Closed Access

An upgraded solid‐phase assembly of chelators (DOTA and NOTA) enabled bacterial uptake studies of radiolabeled peptide
B. Pati, Anuj Kumar, Arnab Chowdhury, et al.
ChemBioChem (2024) Vol. 26, Iss. 1
Closed Access

SOMATOSTATIN ANALOGUES FOR THE TREATMENT OF NEUROENDOCRINE TUMOURS. DOSAGE FORMS AND ROUTES OF ADMINISTRATION (REVIEW)
З. С. Шпрах
International Journal of Applied Pharmaceutics (2020), pp. 6-11
Open Access | Times Cited: 2

Targeted treatment with somatostatin analogues: widening horizons of clinical practice
Vyacheslav Pronin, М. Б. Анциферов, T. M. Alexeeva, et al.
Almanac of Clinical Medicine (2022) Vol. 50, Iss. 3, pp. 196-204
Open Access | Times Cited: 1

Bioanalysis of lanreotide in dog plasma using liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study of beagle dogs after single subcutaneous injection
Tae‐Heon Kim, Seungmok Choi, Duck-soo Lim, et al.
Journal of Chromatography B (2021) Vol. 1188, pp. 123078-123078
Closed Access | Times Cited: 1

Miscellaneous Hormones
Renee McCafferty, Rozette Fawzy
Side effects of drugs annual (2017), pp. 447-455
Closed Access

Page 1 - Next Page

Scroll to top